CASI - CASI Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CASI is currently covered by 3 analysts with an average price target of $14.5. This is a potential upside of $12.16 (519.66%) from yesterday's end of day stock price of $2.34.

CASI Pharmaceuticals's activity chart (see below) currently has 3 price targets and 10 ratings on display. The stock rating distribution of CASI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 95.25 days.

Highest price target for CASI is $12, Lowest price target is $12, average price target is $14.5.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 15-Nov-2023. First documented stock forecast 24-Mar-2020.

Best performing analysts who are covering CASI - CASI Pharmaceuticals:

Justin Zelin Sean Lee Leland Gershell Swayampakula Ramakanth

Currently out of the existing stock ratings of CASI, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

$8.89 (285.85%)

10

5 months 3 days ago

0/3 (0%)

$7.65 (175.86%)

Buy

4

1 years 5 months 2 days ago

1/2 (50%)

$0.72 (21.95%)

73

Buy

12

$8.89 (285.85%)

1 years 8 months 3 days ago

1/2 (50%)

$7.98 (198.51%)

308

Buy

50

1 years 10 months 23 days ago

0/1 (0%)

$32.3 (182.49%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CASI (CASI Pharmaceuticals) average time for price targets to be met?

On average it took 95.25 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on CASI (CASI Pharmaceuticals) with a proven track record?

JUSTIN ZELIN

Which analyst has the current lower performing score on CASI (CASI Pharmaceuticals) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on CASI (CASI Pharmaceuticals)?

Justin Zelin works at BTIG and has 6 price targets and 3 ratings on CASI

Which analyst is the currently most bullish on CASI (CASI Pharmaceuticals)?

Swayampakula Ramakanth with highest potential upside - $8.89

Which analyst is the currently most reserved on CASI (CASI Pharmaceuticals)?

Justin Zelin with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?